Euglycemic Diabetic Ketoacidosis Associated With SGLT2 Inhibitor Therapy: A Case Report.

IF 2 Q2 NURSING

AACN Advanced Critical Care Pub Date : 2023-03-15 DOI:10.4037/aacnacc2023830

Gwen Klinkner, Maggie Steingraber-Pharr

引用次数: 1

Abstract

Sodium-glucose cotransporter-2 inhibitors are now considered second-line treatment agents for type 2 diabetes and offer a unique treatment approach with added cardiorenal benefits. Drugs in this class increase the risk of euglycemic diabetic ketoacidosis, which may be difficult to diagnose if clinicians are not aware of the risk factors and subtle symptoms. This article describes a case of euglycemic diabetic ketoacidosis in a patient with coronary artery disease who was taking a sodium-glucose cotransporter-2 inhibitor and experienced acute mental status changes immediately after heart catheterization.

查看原文本刊更多论文

与SGLT2抑制剂治疗相关的糖尿病酮症酸中毒1例报告。

钠-葡萄糖共转运蛋白-2抑制剂现在被认为是2型糖尿病的二线治疗药物，提供了一种独特的治疗方法，增加了心肾益处。这类药物增加了正常血糖型糖尿病酮症酸中毒的风险，如果临床医生不了解危险因素和细微症状，可能难以诊断。这篇文章描述了一例正糖型糖尿病酮症酸中毒的冠状动脉疾病患者，他服用钠-葡萄糖共转运蛋白-2抑制剂，心导管置入术后立即出现急性精神状态改变。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

AACN Advanced Critical Care NURSING-

CiteScore

2.10

自引率

4.50%

发文量

期刊介绍： AACN Advanced Critical Care is a quarterly, peer-reviewed publication of in-depth articles intended for experienced critical care and acute care clinicians at the bedside, advanced practice nurses, and clinical and academic educators. Each issue includes a topic-based symposium, feature articles, and columns of interest to critical care and progressive care clinicians. AACN Advanced Critical Care contains concisely written, practical information for immediate use and future reference. Continuing education units are available for selected articles in each issue. AACN Advanced Critical Care is an official publication of the American Association of Critical-Care Nurses.